hmi public hearings: consumer related issues - … · hmi public hearings: consumer related issues...
TRANSCRIPT
HMI Public Hearings: Consumer related issues Dr Jonathan Broomberg – CEO Discovery Health 2nd March 2016
Key observations
2
Structure of private
healthcare funding
01
Drivers of medical
inflation
02
\
Quality of care
04
• Discovery Health provides administration and managed care services to Discovery Health Medical Scheme and 17 restricted
medical schemes through contracts which fully align its incentives with those of its scheme clients
• Administration fees charged to DHMS have been increasing at below CPI since 2008, despite increasing complexity and
intensity of services
• Medical schemes have to maintain a delicate equilibrium between contributions, benefits and regulated reserve levels. This
creates a ‘blame paradox’ in which all stakeholders blame medical schemes for not meeting all of their demands
• Increasing utilisation of services by scheme members is the key driver of medical scheme cost inflation. Hospital and doctor
tariff increases track CPI very closely
• Utilisation is growing by 4.5-5% per annum in open schemes, due mainly to adverse selection, as well as ageing and
increasing disease burden
• The critical problem arising from the incomplete regulatory structure is adverse selection against schemes, and not risk
selection by schemes
• Schemes and administrators receive no routine data on quality of care and outcomes
• Discovery Health is investing substantial resources in measuring, monitoring and communicating quality of care data to
members and providers
• Quality of care and outcomes are being incorporated into value based contracting with all providers
\
Product complexity &
communication
03 • Scheme products are complex in response to widely varying member needs and complex PMB regulations
• Discovery Health and all its client schemes communicate intensively and pro-actively with members on all aspects of their
coverage, and comply fully with PMB legislation and the PMB Code of Conduct
AGENDA
Structure of private healthcare financing 1.
Product complexity & communication 3.
Quality of care 4.
3
Drivers of medical inflation 2.
Discovery Health provides administration and managed
care services in the open and restricted scheme markets
• 2.69 million members
• Competes with 23 open
medical schemes
• 17 closed scheme clients
• 550 000 members
• Total of 67 non-competing
restricted schemes
4
3.3 million members
FIXED FEE
CONTRACTS
FIXED FEE
CONTRACT
NOT-FOR-PROFIT | RESTRICTED SCHEMES
NOT-FOR-PROFIT | OPEN SCHEME
DH competes on: product innovation, service excellence, effective claims risk and fraud management and quality of care
Discovery Health’s incentives are fully aligned with its scheme
clients | Membership growth is a critical objective Discovery Health Strategic
Objectives
Impact on Restricted & Open
Schemes
Benefit to Discovery Health
Reduce healthcare costs without
compromising quality
Improve quality of care received by scheme
members
Design suitable benefit plans and
communicate effectively; Build extensive,
cost effective-provider networks
Provide excellent service to all
stakeholders
Make members healthier
Keep administration cost increases in line
with or below CPI
#1
#2
#3
#4
#5
#6
• Lower claims costs
• Lower premiums
• Improved quality of care and fewer adverse
incidents/errors
• Lower claims costs due to reduced waste
• Compliance with PMB regulations
• 90% of members see contracted doctors
• Reduced co-payments
• Members more satisfied with benefits and fewer
complaints
• Stakeholders satisfied with service levels and
fewer complaints
• Increased awareness of health risks
• Increased employer and member loyalty
• Reduced claims costs
• Real decrease in administration fees
• Lower premiums
Restricted Schemes
DH more competitive in
closed scheme market,
leading to new contracts
and increasing fee
revenues
DHMS
DHMS more competitive in
open scheme market, leading
to membership growth, and
increasing fee revenues
5
6
Discovery Health provides a comprehensive set of services to
all scheme clients
MEDICAL SCHEME Board of trustees, Governance, Structures & Policies GOVERNANCE
Benefit Management and Care Administration and
servicing
Marketing and Distribution Research and Development
New Business and Underwriting
Service Operations
Premium Collection
Claims Payment
People
Marketing
Technical Marketing
Distribution
Research and Innovation
Benefit and Product Design
Annual benefit and plan revision
Additional products & services
Managed Care Operations
Disease Management
Provider Relations and Network Management
Co-ordinated Care
Supply-side Development
Support to Brokers
Risk Management
IT and Systems
New business and admin Clinical Systems Channel
Applications Corporate
Applications Applications
Infrastructure Data Analytics
Actuarial Clinical Policy Unit Risk Intelligence Forensics Clinical Risk
Management
Enterprise Architecture
Healthcare funding is complex and increasingly transaction
intensive
7
9,000 35,000
219,000 1,120
R430m
1,700 2,700
51,000 47,000
TRANSACTIONS PER DAY
>4000 Employees
1000 Call centre agents
500 Health professionals,
actuaries & analysts
360 System engineers
SIGNIFICANT INVESTMENT IN HUMAN CAPITAL
Premiums
billed and
claims paid
New
policies
activated
Claims
received Hospital
admissions
Chronic
applications
HIV
registered
members
Oncology
patients
Calls Emails
Chronic
patients 550,000
8
Administration fees reducing as proportion of contributions
Claims 86,2%
Admin & Managed Care Fee
10,4%
Broker & Scheme
2,5%
Surplus to member reserves
0,9%
2015 DHMS
Expense
Breakdown
Administration Fees as a percentage of gross contribution income
Administration fees negotiated on a 3 yearly cycle.
Effective annual increase of CPI -1%
13,4%
13,1%
12,7%
12,0%
11,6%
11,0%
10,7% 10,4%
10.3%
11,8%
2008 2009 2010 2011 2012 2013 2014 2015unaudited
2016projected
DHMS Other Open Medical Schemes
Other open medical
schemes
87% of DHMS’s contributions are for claims
and reserves
9
DHMS administration fees are deflationary
Discovery Health Medical Scheme
(% growth in pabpm costs – 2008 baseline)
Administration fees
Total claims inflation
-4,2%
69,8%
-10,00%
0,00%
10,00%
20,00%
30,00%
40,00%
50,00%
60,00%
70,00%
80,00%
2008 2009 2010 2011 2012 2013 2014 2015
Cumulative increases above CPI
Medical Schemes have to maintain equilibrium between
competing requirements
10
Contributions
Contributions Equilibrium = Reserves Benefits
Contributions
The “Blame paradox” – medical schemes are caught in the
middle
• Low premiums
• Rich benefits
• Simple products
• No restrictions on access to
services, medication, technologies
• Freedom to choose providers
• No co-payments
• Seamless, excellent service
Members:
• Freedom to make clinical decisions
without interference
• Immediate use of latest
technologies, regardless of cost
• High remuneration/return on capital
invested
• No administrative burden
Healthcare Providers:
• Open enrolment and community rating
• Low premiums
• Low administration fees
• High and rigid solvency requirements
• Complex PMB regulations
Regulator / Legislation
Medical Scheme
Board of Trustees
11
AGENDA
Structure of private healthcare financing 1.
Product complexity & communication 3.
Quality of care 4.
12
Drivers of medical inflation 2.
Utilisation of services is the major driver of gap between CPI
and premium inflation; tariff increases closely track CPI
13
6,3% 0,5%
2,9%
1,7% 11,4%
CPI Tariffs Demand sideutilisation
Supply sideutilisation
Claims inflation
Average annualised inflation rates (2008 -2015)
If utilisation was constant
since 2008, premiums would
be 27% lower
If tariff differential was 0%,
since 2008, premiums would
be 2.8% lower
Data from several stakeholders confirms utilisation as the
major driver of gap between CPI and premium inflation
14
5,50% 6,70%
5,10% 5,80% 5,90%
0,55%
0,40% 1,15% 1,40%
2,60%
4,85% 4,20% 3,58% 4,50%
3,70%
Ave
rag
e a
nn
au
l in
cre
ase
Utilisation
Tariff
CPI
Source: Summary of data received by the Commission
Note: * Figures from Medscheme were estimated assuming the residual impact was split 50:50 between tariff and utilisation
• No dissenting
views on
utilisation as
key cause of
medical
inflation
• DH data: more
than 2/3rds of
utilisation is
due to anti-
selection and
demographic
changes
2008-2013
*
Adverse selection drives utilisation and cost increases in
open medical schemes
15
Young people opt out of medical
schemes
Medical schemes have higher
proportions of older people
“Impact of adverse
selection estimated at
R13.5bn – 23% of total contributions for
open medical
schemes”1
Source: 1 Barry Childs, Lighthouse Actuarial Consulting
MEDICAL SCHEME POPULATION TOTAL POPULATION
DISTRIBUTION
RISK SELECTION IS NOT A PROBLEM IN THIS ENVIRONMENT
Evidence of adverse selection in DHMS
16
2008 2015
31,51
33,68
13,90%
22,10%
60,10% 49,80%
From Risk Benefits; If Savings Accounts included, then non-claimants drop from 27.9% in 2008 to 20.7% in 2015
6.9%
59%
21%
% Chronic
Age
% Non-
claimants*
Serious illness should be randomly distributed by duration
17
17%
11% 10%
6%
9%
6% 7%
9%
5% 5% 6%
5%
2%
1% 0%
1 2 3 4 5 6 7 8 9 10 11 12 13 14 >15
Years on Scheme
14%
4%
5%
6%
5%
8%
6%
7%
9% 9% 9%
5%
4%
3%
2% 2%
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 > 15
Years on Scheme
14% who claimed biologics for RA and related conditions had
been on the Scheme for <1 year 17% who claimed biologics for multiple sclerosis had been on
the Scheme for <1 year
Multiple Sclerosis Rheumatoid Arthritis and related conditions requiring
biologic medicines
R120 000 PER PATIENT
PER ANNUM
R97 000 PER PATIENT
PER ANNUM
Supply side: increase in the supply of hospitals drives an
increase in total admission rates
3.37% increase
in Western Cape
from 4 new
hospitals
YoY Change (September 2015)
3.20% increase
in KZN from 1
new hospital
1.08% increase in
Gauteng from 1
new hospital
The admissions in these three provinces account for more than 80% of all admissions on DHMS
17
Supply side: growing impact of high cost medicines
Effective
treatment
for Hepatitis
C
R1m
(12-week course)
New
treatment
for
Malignant
Melanoma R1.5m - R2m
per course
2008
13 ULTRA-HIGH
COST
CLAIMANTS
69 ULTRA-HIGH
COST CLAIMANTS
High cost medicines entering the market in
large numbers Increasing incidence of ultra high-cost medicine
2014
18
R1,73 million
R3 867
PER ULTRA-HIGH
COST CLAIMANT
AVERAGE COST PER
CLAIMANT
AGENDA
Structure of private healthcare financing 1.
Product complexity & communication 2.
Quality of care 3.
20
Drivers of medical inflation 2.
21
Scheme members vary widely in their preferences and needs
and in income available for scheme premiums
Executive Comprehensive Priority Saver Core KeyCare Smart
SICK:
RICH
BENEFITS
HEALTHY:
RESTRICTE
D BENEFITS
HIGH
INCOME
LOW
INCOME
FREEDOM
OF CHOICE
RESTRICTE
D
NETWORKS
1
1
1
1
3
3
3
3
2
2
2
2
22
PMB regulations force complex product design and
decision making
Classified
as a PMB
YES
NO
Emergency
Elective
Procedure
Pay in full
Member able to
access a DSP?
Pay in full
Pay per benefits
YES
NO
DH and all client schemes comply fully with all aspects of PMB legislation and the CMS PMB Code of Conduct
Member willing to
go to DSP
Member not willing to
go to DSP
Pay in full
Pay per benefits
23
PMB regulations create significant complexity for schemes,
administrators, members and providers
Chronic Disease List
(CDL)
• 27 chronic conditions
• Well defined entry and verification
criteria
• Permanent automatic payment
once member registered
• Well defined medicine and basket
of care entitlements
27 chronic conditions 270 conditions
91% of identified PMB and potential PMB claims are paid in full from risk benefits
Diagnosis-Treatment Pairs
(DTPMB)
• Co-morbidity complexities
• Vague diagnoses
• Multiple sources of diagnosis codes
• Codes change during admission
• Not possible to pay most Out of Hospital claims automatically
• Recognised in PMB Code of Conduct
24
Extensive Member Communication at every point in the
client journey
JOINING ACCESSING THE HEALTHCARE
SYSTEM CLAIMING
Welcome Pack Health Plan Guides
How to access tools and information
Guarantee of Full Cover
Chronic Illness Benefit Designated Service Providers
Plan Comparison www.discovery.co.za
Detailed Broker
information and
training to help guide
plan selection process
Information provided to members on joining
What you are covered for
PMBs
Waiting period
Late joiner penalty Chronic Illness Benefit
25
Member Communication | Accessing the healthcare system
JOINING ACCESSING THE HEALTHCARE
SYSTEM CLAIMING
IVR message when requesting
authorisation provides further
information on PMBs
MAPS tool: MEDICAL AND PROVIDER
SEARCH
Proactive call to members
admitted for an emergency
informing them of any potential
co-pays if not using DSPs
- Designated Service Providers Benefits
relating to plan type
- Waiting periods
- Deductibles
- PMB Cover
- Full cover and avoiding co-payments
- Limits
Hospital pre-authorisation:
Call Centre agent provides
information relating to:
Pre-authorisation
email confirmation
Information also available on website | app
| walk-in-centres
- Authorisation confirmation
- What are you covered for
- PMB Guide
- Clinical Procedure Guide
26
Member Communication | Claiming
JOINING ACCESSING THE HEALTHCARE
SYSTEM CLAIMING
Claims notifications and
claims statements
Details of processed claim
Impact on day-to-day benefits
including breakdown of usage
against limits
Member App
Claims tracking & history
Reason for short/non-payment
Website
Step-by-step guide to
managing claims
Claims summary
Benefits used
Educational Videos
How to apply for a PMB
27
Generic sources of information available for members
Discoverer
BROKER COMMUNICATION DIRECT MEMBER COMMUNICATION
Discovery newsletter Member App
www.discovery.co.za
Health plan guides
Plan Series
Guides
Product Enhancements
Educational videos Library & Info
guides
Discovery Health has a clearly articulated service
escalation and complaints process
28
Client Services TL / Client services Manager
Specialist Consultant / Escalation CRM
Client Services Consultant
Ops /
Service
Exec /
Exec Office
Step 1: Complaint form
Step 2: Contact the Principal Officer
Step 3: Lodge a dispute (with independent Disputes Committee)
Step 4: Contact CMS
Unresolved query
Website App Service Centre Email Call Centre
DHMS dispute resolution process
29
A strong focus on compliance, service and communication
leads to low complaint levels
CMS complaints per thousand DHMS members
Ten open schemes with highest number of
valid complaints per 1 000 beneficiaries 2014
Scheme A 2.9
Scheme B 2.8
Scheme C 2.0
Scheme D 1.0
Scheme E 0.9
Scheme F 0.9
Scheme G 0.9
Scheme H 0.9
Scheme I 0.8
Scheme J 0.7
DHMS does not
feature on the
CMS’ top 10
complaints list
0,55
0,38
0,26 0,28
0
0,1
0,2
0,3
0,4
0,5
0,6
2012 2013 2014 2015
CMS complaints per 1000 beneficiaries in DHMS
<800 CMS complaints
per year out of 43.8
million claims
AGENDA
Structure of private healthcare financing 1.
Product complexity & communication 3.
Quality of care 4.
30
Drivers of medical inflation 2.
31
Schemes and administrators receive very limited data on
quality of care and health outcomes
Law requires the
submission of ICD
codes only
Schemes/Administrators receive no routine data on:
Quality of care Clinical outcomes
Clinical summaries post
hospital discharge
Hospital mortality,
readmission and infection
rates
1 2
3 4
32
Discovery Health is investing substantially in measuring, monitoring
and communicating quality of care data to members and providers
HealthID for doctors Health record for members Patient Satisfaction Survey
(PaSS)
Listening to the Patient’s Voice is a Key Step to Improve
Quality of Care in Hospitals
26%
10%
14%
12%
6%
20%
19%
19%
13%
21%
15%
50%
69%
65%
85%
67%
79%
Medication info
Pain management
Hospitalenvironment
Care from doctors
Responsiveness ofstaff
Care from nurses
Never\Sometimes Usually Always
33
2015
Discovery Health Member Experience Survey
Hospital
Next phase will include hard outcome measures – mortality, re-admission, infection, adverse incidents
Defined daily dosage per 100 bed days, case mix-
adjusted
177
0
20
40
60
80
100
120
140
160
180
200
N=139 hospitals
Average = 77
6,4%
3,5%
5,6%
4,4%
200
8 -
Q1
200
9 -
Q1
201
0 -
Q1
201
1 -
Q1
201
2 -
Q1
201
3 -
Q1
21.4% reduction
N=238 hospitals
Monitoring and improving antibiotic utilisation in private
hospitals
In hospital antibiotic utilisation Decrease in inappropriate surgical prophylaxis,
2008-2013
33
Increasing focus on outcome measurement and improvement
0%
5%
10%
15%
20%
25%
30%
35%
N=111 hospitals
SA average = 7.4%
EU average = 5.5 - 7.8%
35
Mortality rate for Acute Myocardial infarction (%)
2008 - 2011
Note: EU benchmarks are based on national averages, SA figures show Discovery hospital based data. Reasons for deviations from the average mortality rate could be: small number of cases in a
hospital, random variation, different disease burden, quality issues. The detail is analysed for each hospital, and where there are potential quality problems this is discussed with hospital management
and specialists involved.
Discovery Health’s KidneyCare Programme
0%
2%
4%
6%
8%
10%
12%
14%
16%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
55%
60%
65%
70%
75%
80%
85%
90%
95%
100%
Phase 7 Phase 8
5% Improvement in
scores
13,8%
11,2% 9,6%
0%
2%
4%
6%
8%
10%
12%
14%
16%
All chronic dialysis patientsover 5 year period
Non-KidneyCare patients KidneyCare patients (Phase7)
1.6
%
4.2
%
~4,200 kidney failure patients ~1,500 renal dialysis patients 36
Kidney disease mortality rate for
Discovery Health Medical Scheme Population distribution of average member scores
Discovery Health Care Co-ordination Programme impacting
on quality and cost of care
12%
15%
6%
10%
0%
2%
4%
6%
8%
10%
12%
14%
16%
Preventable admission rate Readmission rateNormal patient CCP patient
% admissions
1,00
1,51
1,10
1,00
0,9
1,1
1,3
1,5
3 6 9 12
Month since intervention
CCP Patient
Normal Patient
Cost index
34%
Mobility & Cognitive Assessments
Pre Post
67% 50%
33%
37
Improved quality Lower cost per event Decreased hospital admissions
VALUE IN HEALTHCARE | Discovery Healting shifting to
contracting for value, including cost and quality measures
Value
= max Cost
lowest
Quality best
Measure outcomes and costs
2
Move to bundled payments
3
Integrate practice units & delivery systems
1
4
38
Several cost and quality improvement projects with
specialist groups using bundled payments
Doctor Guided Funding Model for Coronary Artery Disease
INITIAL
RESULTS
41 interventional
cardiology practices
participating
Zero adverse patient
outcomes
Empowered
cardiologists with no
loss of earnings
Early Cost savings
73% increase in CT
scan rate
39
Meaningful reduction
in angiograms
SASCI Project
HMI Public Hearings Dr Jonathan Broomberg – CEO Discovery Health 2nd March 2016